David Sidransky

David Sidransky (board member) discloses dealings in 3 companies, chiefly Champions Oncology, Inc., Ayala Pharmaceuticals, Inc. and Old Ayala, Inc. Over a trading history stretching from 15 October 2021 to 19 January 2023, the count stands at 4 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 23 January 2023, the filings show a share grant in Ayala Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.